Cargando…
Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer
Desloratadine, a potent antagonist for human histamine H1 receptor, has been revealed to exhibit antihistaminic activity and anti-inflammatory activity. However, it is not yet known whether desloratadine has any effect on the biological behaviors of tumor cells. In this study, we aimed to investigat...
Autores principales: | Ma, Jianfeng, Qi, Jinchun, Li, Shoubin, Zhang, Chaohua, Wang, Haijiang, Shao, Lijun, Yuan, Xiaofei, Sha, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238774/ https://www.ncbi.nlm.nih.gov/pubmed/32406319 http://dx.doi.org/10.1177/1533033820926591 |
Ejemplares similares
-
Desloratadine Induced Pill Esophagitis
por: Alkim, Huseyin, et al.
Publicado: (2012) -
Ferritin heavy chain (FTH1) exerts significant antigrowth effects in breast cancer cells by inhibiting the expression of c‐MYC
por: Ali, Amjad, et al.
Publicado: (2021) -
Development and validation of an improved LC-MS/MS method for the quantification of desloratadine and its metabolite in human plasma using deutrated desloratadine as internal standard
por: Hasnain, M. Saquib, et al.
Publicado: (2013) -
Berbamine (BBM), a Natural STAT3 Inhibitor,
Synergistically Enhances the Antigrowth and Proapoptotic Effects of
Sorafenib on Hepatocellular Carcinoma Cells
por: Zhao, Weijia, et al.
Publicado: (2020) -
In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine
por: Howell, G, et al.
Publicado: (2005)